EKF Diagnostics Holdings plc

Equities

EKF

GB0031509804

Advanced Medical Equipment & Technology

Market Closed - London S.E. Other stock markets 09:05:13 04/07/2024 pm IST			5-day change	1st Jan Change
28.7 ^GBX	+1.41%		+3.05%	-9.32%

15/05	Future Metals celebrates state government grant	AN
14/05	EKF Diagnostics Holdings Says Q1 Adj EBITDA Shows About 20% Improvement	RE

Lurene Joseph Joins EKF Diagnostics Holdings plc as Non-Executive Director

December 21, 2015 at 12:30 pm IST

EKF Diagnostics Holdings plc announced that Lurene Joseph joins the Board as a non-executive director with immediate effect. Lurene has held Chief Executive positions at Leeds and Partners Limited and the London Development Agency.

Latest news about EKF Diagnostics Holdings plc

Future Metals celebrates state government grant	16/05	AN
EKF Diagnostics Holdings Says Q1 Adj EBITDA Shows About 20% Improvement	14/05	RE
Onward Opportunities' small-cap strategy yields solid results in 2023	11/04	AN
EKF Diagnostics says prospects "promising" but pauses dividends	20/03	AN
EKF Diagnostics Holdings plc Reports Earnings Results for the Full Year Ended December 31, 2023	20/03	CI
EKF Diagnostics reports trading in line with expectations	30/01	AN
EKF Diagnostics Holdings plc Provides Earnings Guidance for the Full Year 2023	29/01	CI
EKF Diagnostics Holdings plc Announces the Official Opening of its New State-Of-The-Art Life Sciences Manufacturing Site in South Bend, Indiana, United States	26/23/26	CI
EARNINGS: FireAngel Safety interim loss widens amid ongoing headwinds	26/23/26	AN
Earnings Flash (EKF.L) EKF DIAGNOSTICS HOLDINGS Reports H1 Revenue GBP26.9M	26/23/26	MT
EKF Diagnostics Holdings plc Reports Earnings Results for the Half Year Ended June 30, 2023	26/23/26	CI
FTSE 100 Closes Tuesday Up 0.41% as Oil-Price Rises Benefit the Index	12/23/12	DJ
EKF Diagnostics hires CFO from Trellus Health, latter names successor	12/23/12	AN
FTSE 100 Rises, Led by AB Foods; Smurfit Kappa Slides	12/23/12	DJ
Trellus Health's Interim Finance Head Takes Full-time CFO Role at EKF Diagnostics	12/23/12	MT
EKF Diagnostics Holdings plc Provides Financial Guidance for the Year Ending 31 December 2023	12/23/12	CI
EKF Diagnostics Holdings plc Appoints Stephen Young as Chief Financial Officer	12/23/12	CI
Revolution Bars reports good progress from Peach Pubs	27/23/27	AN
FTSE 100 Closes Down 0.2% as Miners Offset Ocado, -2-	26/23/26	DJ
FTSE 100 Closes Up 0.5% as Sage Group Shines	28/23/28	DJ
SONIA Illiquidity Could Explain Disconnect in BOE Peak Rate Pricing	28/23/28	DJ
EKF Diagnostics says CFO Davies resigns to pursue other opportunities	28/23/28	AN
EKF Diagnostics CFO Plans Exit; Successor to Assume Role in Q4	28/23/28	MT
Marc Davies to Step Down as Chief Financial Officer of EKF Diagnostics Holdings plc	28/23/28	CI
EKF Diagnostics announces enzyme fermenter progress	20/23/20	AN

Chart EKF Diagnostics Holdings plc

Duration

Period

More charts

Company Profile

EKF Diagnostics Holdings plc is a United Kingdom-based diagnostics company. The Company is engaged in point-of-care testing, central laboratory tests, enzyme manufacturing and the provision of contract manufacturing services to the healthcare industry. Its principal activity is the development, manufacture and supply of products into the in-vitro diagnostics marketplace. Its point of care analyzers is designed for use within doctors' surgeries, clinics, blood banks and hospital and private laboratories to provide results. Its life sciences specialize in producing enzymes and contracted custom products for use in medical diagnostics, pharmaceuticals and industry. Its life science facilities are based in two locations in Indiana, United States. Its central laboratory division manufactures a spectrum of reagents for use in hospital laboratories. Its contract manufacturing business provides specialized services to the diagnostics and healthcare industries for the production of custom kits.

Sector

Advanced Medical Equipment & Technology

Calendar

10/09/2024 - Q2 2024 Earnings Release (Projected)

More about the company